LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Articles
Sanotize Research and Development Corp.
Headquarters:
Vancouver, Canada
Website:
https://sanotize.com/
Year Founded:
2017
Status:
Private
BioCentury
|
Apr 2, 2025
Management Tracks
Change at the top for Phathom as Basta replaces Curran
Plus: Updates from Nuage, GV, Inhibrx, Lyell, Repare, Adcendo, ITM Isotope, Transgene and Novartis
Read More
BioCentury
|
Sep 27, 2023
Management Tracks
Syncona-backed Forcefield names Novartis vet Tsai CEO
Plus: PureTech hires Arix CEO Lyne and updates from InterVenn, Veracyte, Arcutis, Strata, Sanotize, Caribou, Mati
Read More
BioCentury
|
Jan 18, 2023
Management Tracks
AZ’s Marshall becomes CEO of Juvenescence
Plus: Gomez retires as CEO from Siga, and updates from Full-Life, Remix, Sanotize and more
Read More
BioCentury
|
Aug 25, 2022
Deals
Aug. 24 Quick Takes: EC approves BioMarin’s hemophilia A gene therapy
Plus Ovid, Gensaic in gene therapy deal and updates from Digital Diagnostics, BioInnovation Institute, Moderna, Relief and more
Read More
Items per page:
10
1 - 4 of 4